 Transplantation Conditioning
"Transplantation Conditioning" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Preparative treatment of transplant recipient with various conditioning regimens including radiation, immune sera, chemotherapy, and/or immunosuppressive agents, prior to transplantation. Transplantation conditioning is very common before bone marrow transplantation.
| Descriptor ID |
D019172
|
| MeSH Number(s) |
E02.095.465.425.450.800 E05.478.610.800
|
| Concept/Terms |
Transplantation Conditioning- Transplantation Conditioning
- Conditioning, Transplantation
- Conditionings, Transplantation
- Transplantation Conditionings
|
Below are MeSH descriptors whose meaning is more general than "Transplantation Conditioning".
Below are MeSH descriptors whose meaning is more specific than "Transplantation Conditioning".
This graph shows the total number of publications written about "Transplantation Conditioning" by people in this website by year, and whether "Transplantation Conditioning" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 | | 1997 | 2 | 2 | 4 | | 1998 | 1 | 1 | 2 | | 1999 | 2 | 1 | 3 | | 2000 | 1 | 4 | 5 | | 2001 | 3 | 2 | 5 | | 2002 | 2 | 4 | 6 | | 2003 | 3 | 4 | 7 | | 2004 | 4 | 5 | 9 | | 2005 | 4 | 1 | 5 | | 2006 | 4 | 4 | 8 | | 2007 | 1 | 1 | 2 | | 2008 | 4 | 0 | 4 | | 2009 | 7 | 5 | 12 | | 2010 | 3 | 9 | 12 | | 2011 | 7 | 6 | 13 | | 2012 | 2 | 2 | 4 | | 2013 | 11 | 6 | 17 | | 2014 | 6 | 1 | 7 | | 2015 | 12 | 1 | 13 | | 2016 | 3 | 5 | 8 | | 2017 | 6 | 2 | 8 | | 2018 | 1 | 2 | 3 | | 2019 | 3 | 1 | 4 | | 2020 | 0 | 4 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Transplantation Conditioning" by people in Profiles.
-
van Besien K, Orfali N, Shore T. Allogeneic Transplant Conditioning Regimens for Patients With Non-Hodgkin Lymphoma. JAMA Oncol. 2020 12 01; 6(12):1983-1984.
-
Hsu J, Van Besien K, Baron F. Busulfan or melphalan: is there a better conditioning regimen for allogeneneic transplantation? Leuk Lymphoma. 2020 07; 61(7):1529-1534.
-
van Besien KW, Orfali N. Alternative Donor Transplantation for Lymphoid Malignancies: How Far We Have Come. J Clin Oncol. 2020 05 10; 38(14):1501-1504.
-
Orfali N, van Besien K. Combining haplo-identical and cord blood stem cell grafts - might the whole be greater than the sum of its parts? Leuk Lymphoma. 2020 04; 61(4):753-756.
-
DeFilipp Z, Advani AS, Bachanova V, Cassaday RD, Deangelo DJ, Kebriaei P, Rowe JM, Seftel MD, Stock W, Tallman MS, Fanning S, Inamoto Y, Kansagra A, Johnston L, Nagler A, Sauter CS, Savani BN, Perales MA, Carpenter PA, Larson RA, Weisdorf D. Hematopoietic Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Updated 2019 Evidence-Based Review from the American Society for Transplantation and Cellular Therapy. Biol Blood Marrow Transplant. 2019 11; 25(11):2113-2123.
-
Jabbour EJ, Gökbuget N, Kantarjian HM, Thomas X, Larson RA, Yoon SS, Ghobadi A, Topp MS, Tran Q, Franklin JL, Forman SJ, Stein AS. Transplantation in adults with relapsed/refractory acute lymphoblastic leukemia who are treated with blinatumomab from a phase 3 study. Cancer. 2019 Dec 01; 125(23):4181-4192.
-
van Besien K, Artz A, Champlin RE, Guarneri D, Bishop MR, Chen J, Gergis U, Shore T, Liu H, Rondon G, Mayer SA, Srour SA, Stock W, Ciurea SO. Haploidentical vs haplo-cord transplant in adults under 60 years receiving fludarabine and melphalan conditioning. Blood Adv. 2019 06 25; 3(12):1858-1867.
-
Van Besien K, Bachier-Rodriguez L, Satlin M, Brown MA, Gergis U, Guarneri D, Hsu J, Phillips AA, Mayer SA, Singh AD, Soave R, Rossi A, Small CB, Walsh TJ, Rennert H, Shore TB. Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high risk. Leuk Lymphoma. 2019 07; 60(7):1693-1696.
-
Thakar MS, Broglie L, Logan B, Artz A, Bunin N, Burroughs LM, Fretham C, Jacobsohn DA, Loren AW, Kurtzberg J, Martinez CA, Mineishi S, Nelson AS, Woolfrey A, Pasquini MC, Sorror ML. The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases. Blood. 2019 02 14; 133(7):754-762.
-
Choe H, Gergis U, Hsu J, Phillips A, Shore T, Christos P, van Besien K, Mayer S. Bortezomib and Immune Globulin Have Limited Effects on Donor-Specific HLA Antibodies in Haploidentical Cord Blood Stem Cell Transplantation: Detrimental Effect of Persistent Haploidentical Donor-Specific HLA Antibodies. Biol Blood Marrow Transplant. 2019 02; 25(2):e60-e64.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|